Literature DB >> 3762281

Extended experimental and preliminary surgical findings with autologous fibrin tissue adhesive made from patients own blood.

K H Siedentop, D M Harris, K Ham, B Sanchez.   

Abstract

A surgical tissue adhesive can be made from the patient's own blood. We have been refining the procedures for manufacturing autologous fibrin tissue adhesive to facilitate its use in the operating room and to increase its bonding strength. Fibrin tissue adhesive efficacy depends on fibrinogen concentration. We found that fibrinogen precipitation using the ammonium sulfate method produced the highest concentration. Bonding power was compared with that of the commercial glue 10 minutes and 30 minutes after glueing two pieces of 1 X 1 cm2 human dura together. Bonding strength of the autologous product was close to that of the commercial product. Comparisons of fibrinolysis inhibition time of autologous fibrin tissue adhesive and commercial glue in experiments on rats over a period of one hour to six days after subcutaneous injection are described.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3762281     DOI: 10.1288/00005537-198610000-00003

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  [Realistic early and late results after otosclerosis surgery and presentation of a technique involving almost no complications].

Authors:  H Schobel
Journal:  HNO       Date:  2004-12       Impact factor: 1.284

2.  Prevention of cerebrospinal fluid leaks and transtemporal surgery of acoustic tumors.

Authors:  A Kumar; K H Siedentop
Journal:  Skull Base Surg       Date:  1992

3.  CT-guided percutaneous injection of fibrin glue for the therapy of symptomatic arachnoid cysts.

Authors:  Z Shao; B Wang; Y Wu; Z Zhang; Q Wu; S Yang
Journal:  AJNR Am J Neuroradiol       Date:  2011-08-11       Impact factor: 3.825

4.  Pepsin fibrinolysis of artificial clots made from fibrinogen concentrate and bovine thrombin: the effect of pH and epsilon aminocaproic acid.

Authors:  G A Valenzuela; W D Spotnitz; D D Stone
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

5.  Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

Authors:  M J Rybak; H H Houlihan; R C Mercier; G W Kaatz
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

6.  Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.

Authors:  S M Palmer; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

7.  Percutaneous fibrin gel injection under C-arm fluoroscopy guidance: a new minimally invasive choice for symptomatic sacral perineural cysts.

Authors:  Wei Jiang; QuanHe Qiu; Jie Hao; XiaoJun Zhang; Wei Shui; ZhenMing Hu
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 8.  Fibrin Sealant: The Only Approved Hemostat, Sealant, and Adhesive-a Laboratory and Clinical Perspective.

Authors:  William D Spotnitz
Journal:  ISRN Surg       Date:  2014-03-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.